Insider · CIK 0001814150
Stacy Ann Coen
Files at IMGN (ImmunoGen, Inc.), FBLG (FibroBiologics, Inc.). First filing Nov 17, 2023, latest Dec 5, 2023.
In brief
Stacy Ann Coen files SEC Form 4 as director and officer at IMGN (ImmunoGen, Inc.), and also at FBLG (FibroBiologics, Inc.). Since Nov 17, 2023, Stacy Ann Coen has reported 0 open-market buys worth $0 and 2 open-market sells worth $1.9M, the latest filed on Dec 5, 2023.
A track record needs three past buys with six months of prices behind them; Stacy Ann Coen has 0, so none is measured yet.
The newest scored trade: sold $112k of IMGN on Nov 30, 2023, filed Dec 5, 2023, scored 25 (weak), under a 10b5-1 plan.
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 25Weak | ImmunoGen, Inc. | $112k 3,826 shares | -10% | - | |
| 40Moderate | ImmunoGen, Inc. | $1.7M 108,609 shares | -172% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 1, 2023 | ImmunoGen, Inc. | 3,826 0.00% of outstanding | $112k | Nov 30, 2023 | $1.7M |
| Nov 17, 2023 | ImmunoGen, Inc. | 78,223 0.03% of outstanding | $1.3M | Nov 17, 2023 | $487k |
| Nov 16, 2023 | ImmunoGen, Inc. | 4,100 0.00% of outstanding | $66k | Nov 16, 2023 | $421k |
| Nov 15, 2023 | ImmunoGen, Inc. | 26,286 0.01% of outstanding | $421k | Nov 15, 2023 | none |
Transactions
Every row this insider has filed, 17 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 12, 2025 | FBLG FibroBiologics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +22,000 | $0.00 | $0 | 22,000 | Jun 12, 2025 |
| Nov 30, 2023 | IMGN ImmunoGen, Inc. | SOpen-market sale Common Stock10b5-1 | -3,826 | $29.20 | $112k | 33,140 | Dec 5, 2023 |
| Nov 15, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Common Stock10b5-1 | +20,986 | $4.92 | $103k | 57,952 | Nov 17, 2023 |
| Nov 15, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Common Stock10b5-1 | +5,300 | $7.69 | $41k | 63,252 | Nov 17, 2023 |
| Nov 15, 2023 | IMGN ImmunoGen, Inc. | SOpen-market sale Common Stock10b5-1 | -26,286 | $16.01 | $421k | 36,966 | Nov 17, 2023 |
| Nov 16, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Common Stock10b5-1 | +3,200 | $4.92 | $16k | 40,166 | Nov 17, 2023 |
| Nov 16, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Common Stock10b5-1 | +900 | $7.69 | $6,921 | 41,066 | Nov 17, 2023 |
| Nov 16, 2023 | IMGN ImmunoGen, Inc. | SOpen-market sale Common Stock10b5-1 | -4,100 | $16.01 | $66k | 36,966 | Nov 17, 2023 |
| Nov 17, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Common Stock10b5-1 | +2,200 | $4.92 | $11k | 39,166 | Nov 17, 2023 |
| Nov 17, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Common Stock10b5-1 | +76,023 | $7.69 | $585k | 115,189 | Nov 17, 2023 |
| Nov 17, 2023 | IMGN ImmunoGen, Inc. | SOpen-market sale Common Stock10b5-1 | -78,223 | $16.05 | $1.3M | 36,966 | Nov 17, 2023 |
| Nov 15, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -20,986 | $0.00 | $0 | 54,223 | Nov 17, 2023 |
| Nov 15, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -5,300 | $0.00 | $0 | 153,710 | Nov 17, 2023 |
| Nov 16, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -3,200 | $0.00 | $0 | 51,023 | Nov 17, 2023 |
| Nov 16, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -900 | $0.00 | $0 | 152,810 | Nov 17, 2023 |
| Nov 17, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -2,200 | $0.00 | $0 | 48,823 | Nov 17, 2023 |
| Nov 17, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -76,023 | $0.00 | $0 | 76,787 | Nov 17, 2023 |
Questions about Stacy Ann Coen
Answered from the filings on this page, as of the latest one.
Is Stacy Ann Coen buying or selling?
Not in the last 12 months. Stacy Ann Coen's latest open-market trade on SEC Form 4 was sold $112k of IMGN on Nov 30, 2023.
How did Stacy Ann Coen's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Stacy Ann Coen has 0.
Where does Stacy Ann Coen file Form 4?
Stacy Ann Coen has filed Form 4 at IMGN (ImmunoGen, Inc.) as SVP & CHIEF BUSINESS OFFICER; FBLG (FibroBiologics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.